Realtime | Geld | Brief | Zeit |
---|---|---|---|
3,725 | 3,855 | 23.04. | |
3,790 | 3,840 | 23.04. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | OTC Markets Group Welcomes ONWARD Medical N.V. to OTCQX | 43 | GlobeNewswire (Europe) | NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced ONWARD Medical... ► Artikel lesen | |
01.04. | ONWARD Medical NV: ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights | 403 | GlobeNewswire (Europe) | Received FDA authorization and recorded first commercial sales of ARC-EX System
Secured strategic investment from Ottobock and extended cash runway for two years
Gained exclusive rights to premier... ► Artikel lesen | |
26.03. | ONWARD Medical NV: ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility | 313 | GlobeNewswire (Europe) | The ARC-IM Lumbar Lead is the second model in the ARC-IM Lead family to be used in a clinical feasibility study
The Company is building a portfolio of purpose-designed leads to optimize delivery... ► Artikel lesen | |
19.03. | ONWARD Medical NV: ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast | 391 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, March 19, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement... ► Artikel lesen | |
04.03. | ONWARD Medical NV: ONWARD Medical to Advance Parkinson's Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense | 658 | GlobeNewswire (Europe) | The Michael J. Fox Foundation for Parkinson's Research is supporting a study addressing mobility challenges in Parkinson's disease; the first participant was enrolled in late 2024
A US Department... ► Artikel lesen | |
25.02. | ONWARD Medical NV: ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy | 372 | GlobeNewswire (Europe) | Study shows significant functional improvements after one year of ARC-EX Therapy
Improvements were observed throughout one-year treatment period with no plateau
Results demonstrate the importance... ► Artikel lesen | |
29.01. | ONWARD Medical NV: ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms | 424 | GlobeNewswire (Europe) | ONWARD ARC-EX System for spinal cord injury is now available for purchase through VA Federal Supply Schedule and GSA Advantage platforms
Partnership with Lovell Government Services is providing... ► Artikel lesen | |
13.01. | ONWARD Medical NV: ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference | 431 | GlobeNewswire (Europe) | CEO Dave Marver to Provide Company Update Wednesday, January 15, 2025EINDHOVEN, the Netherlands, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company... ► Artikel lesen | |
ONWARD MEDICAL Aktie jetzt für 0€ handeln | |||||
09.01. | ONWARD Medical NV: ONWARD Medical Announces First Commercial Sales of ARC-EX System | 581 | GlobeNewswire (Europe) | UW Medicine and Next Steps Chicago both purchased systems in late December 2024
ARC-EX is the first and only FDA approved technology indicated to improve hand strength and sensation in people with... ► Artikel lesen | |
19.12.24 | ONWARD Medical NV: ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World's First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury | 519 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
ARC-EX System is the first and only FDA approved technology... ► Artikel lesen | |
12.12.24 | ONWARD Medical NV: ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability | 732 | GlobeNewswire (Europe) | EcoVadis silver medal recognizes Company's environmental and social impact
Demonstrates ongoing commitment to integrating sustainable business practices
EINDHOVEN, the Netherlands, Dec. 12,... ► Artikel lesen | |
26.11.24 | ONWARD Medical NV: ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights | 487 | GlobeNewswire (Europe) | Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company's top investor
Signed exclusive license with CEA to develop and commercialize WIMAGINE Brain-Computer... ► Artikel lesen | |
19.11.24 | ONWARD Medical NV: ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke | 481 | GlobeNewswire (Europe) | Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke
Funding... ► Artikel lesen | |
12.11.24 | ONWARD Medical NV: ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights | 526 | GlobeNewswire (Europe) | Company to provide update on significant milestones and near-term plans, including its recent successful financing and agreements with Ottobock and CEAEINDHOVEN, the Netherlands, Nov. 12, 2024 (GLOBE... ► Artikel lesen | |
04.11.24 | Ottobock becomes Onward Medical's largest shareholder | 5 | MassDevice | ||
31.10.24 | ONWARD Medical NV: ONWARD ARC-EX System Named One of TIME's Best Inventions of 2024 | 473 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, Oct. 31, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence... ► Artikel lesen | |
28.10.24 | ONWARD Medical NV: ONWARD Medical Publishes Closing of Bookbuild Offering | 534 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
EINDHOVEN, the Netherlands, Oct. 28, 2024 (GLOBE NEWSWIRE)... ► Artikel lesen | |
24.10.24 | ONWARD Medical NV: ONWARD Medical Publishes Prospectus for Listing of New Shares | 468 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
EINDHOVEN, the Netherlands, Oct. 24, 2024
This press release... ► Artikel lesen | |
24.10.24 | XFRA 63E: WIEDERAUFNAHME/RESUMPTION | 221 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
24.10.24 | ONWARD Medical NV: ONWARD Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA | 464 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
Ottobock, a global leader in the fields of prosthetics, orthotics... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 39,480 | -0,18 % | Fresenius SE Aktie: Leichte Erholung im Fokus | Fresenius notiert nahe dem Jahreshoch mit soliden technischen und fundamentalen Signalen. Analysten sehen weiteres Kurspotenzial trotz hoher Verschuldung. Die Fresenius-Aktie zeigt sich am Donnerstag... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 42,090 | +0,02 % | BERNSTEIN RESEARCH stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Fresenius Medical Care (FMC) auf "Market-Perform" mit einem Kursziel von 50 Euro belassen. Der Dialyseanbieter... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 45,630 | +1,90 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 53 Euro auf "Neutral" belassen. Bei GE Healthcare, Philips und Siemens Healthineers... ► Artikel lesen | |
CARL ZEISS MEDITEC | 58,80 | -0,76 % | Buy or Goodbye?: Adidas, Allianz, Carl Zeiss Meditec & Beiersdorf - Analystenstimmen des Tages | © Foto: Carl Zeiss Meditec AGUBS senkt das Kursziel für Adidas, während Goldman Sachs das Kursziel für Carl Zeiss Meditec anhebt. Barclays hebt derweil das Kursziel für Allianz an.UBS senkt das Kursziel... ► Artikel lesen | |
ECKERT & ZIEGLER | 54,85 | +3,59 % | Eckert & Ziegler Aktie: Schacht Konrad belastet | Die Aktie von Eckert & Ziegler zeigt sich stabil, doch regulatorische Unsicherheiten um Schacht Konrad könnten den Strahlentechnik-Pionier herausfordern. Die Eckert & Ziegler-Aktie zeigt sich heute... ► Artikel lesen | |
DRAEGERWERK | 60,20 | +3,26 % | Aixtron, Drägerwerk, Evotec, Kontron, Rheinmetall, Werder Bremen - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
MEDTRONIC | 73,86 | -0,04 % | Medtronic: Grammy Award Winning Artist Knows How Math Can Help Prevent Cancer | Anthony Hamilton experiences how Medtronic is using AI to help detect colon polyps NORTHAMPTON, MA / ACCESS Newswire / April 22, 2025 / Grammy Award winning singer and songwriter Anthony Hamilton underwent... ► Artikel lesen | |
INTUITIVE SURGICAL | 431,70 | +0,26 % | Opening Bell: Tesla, Enphase Energy, Intuitive Surgical, Boeing, Apple, Meta, Bitcoin, Strategy | Der Optimismus verfestigt sich langsam an den US-Börsen. Gestern legten die großen Indizes bereits deutlich zu. Heute deuten sich die nächsten Gewinne an. Gleichzeitig müssen die Märkte aber auch viele... ► Artikel lesen | |
GERRESHEIMER | 53,40 | +2,40 % | EQS-PVR: Gerresheimer AG: Korrektur einer Veröffentlichung vom 08.04.2025 gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Korrektur einer Veröffentlichung vom 08.04.2025 gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
16.04.2025... ► Artikel lesen | |
UNITEDHEALTH | 378,30 | +0,25 % | UnitedHealth-Aktie -23%: Jetzt zuschlagen? | Mit einem gewaltigen Kurseinbruch von -23% sorgte die UnitedHealth-Aktie für große Kopfschmerzen bei ihren Anlegern und war damit der ganz große Verlierer am gestrigen Handelstag unter den großen US-Werten.... ► Artikel lesen | |
TELADOC HEALTH | 6,250 | +0,35 % | Jefferies cuts Teladoc price target to $8, maintains hold rating | ||
RHOEN-KLINIKUM | 15,200 | -4,40 % | Klinik für Kardiochirurgie erreicht Meilenstein: 500ste "Kunstherz"-Implantation am RHÖN-KLINIKUM Campus Bad Neustadt | Bad Neustadt a.d. Saale (ots) - Die Klinik für Kardiochirurgie am RHÖN-KLINIKUM Campus Bad Neustadt kann einen bedeutenden Meilenstein in der Behandlung von Herzinsuffizienz verzeichnen: Die Implantation... ► Artikel lesen | |
BIOTEST | 30,000 | 0,00 % | Westbourne River Partners letter to Biotest AG | LONDON, April 15, 2025 /PRNewswire/ -- Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols S.A. to shareholders of Biotest:
Biotest AGAttn.... ► Artikel lesen | |
ROKU | 55,42 | +0,25 % | Roku testet neue Werbeformate: Nutzer reagieren kritisch | ||
ESSILORLUXOTTICA | 258,90 | +0,43 % | JPMORGAN stuft EssilorLuxottica auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für EssilorLuxottica von 280 auf 270 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. Aufgrund jüngster Branchendaten... ► Artikel lesen |